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1. Introduction
In the textile market industry, technical textiles are one of the fastest growing businesses. Part
of that industry consists of textiles for medical and healthcare applications and are responsible
for a continuous increase in its market potential [1]. Next to their need in hospital environ‐
ments, there is a growing demand in other sectors such as the food and hotel industry, due to
stricter hygiene regulations. In most cases biomedical textile meets a well-defined set of
requirements such as minimizing non-specific protein adsorption, drug delivery coatings or
the presence of active functional coatings and most importantly excellent biocompatibility
(blood-, tissue-or cyto-compatibility) [2]. In general there are very few materials meeting all
these characteristics, while at the same time offering the needed structural and mechanical
properties. Furthermore, depending on the application, the production process has to be cost-
effective and approved by local legislation.
In order to meet all these requirements, numerous modification techniques have been
developed in the past [3-5]. Most of these techniques lead to the incorporation of extra/new
functionalities and might lead to a change in surface free energy. For most biomedical
applications, the preservation of material bulk properties such as elasticity, strength, ductility,
structural integrity etc. is critical. For biomedical end-products, the use of solvents and
chemicals based surface treatment techniques are reduced to a strict list approved by local
legislation. Chemical-free techniques such as γ-radiation, UV treatments, corona discharges
etc. have led to some excellent results in the field of tissue engineering [6, 7]. One of those
solvent-free techniques that have been around for over a century, has more recently found its
way into the biomedical field: non-thermal plasma technology.
Over time, it has extensively been proven that non-thermal plasma technology can profoundly
change the surface properties of polymer films (PP, PET, PU, etc.) as well as material charac‐
teristics (adhesion, printability, dyeing etc.) of more complex substrates such as industrially
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produced textile [8-14]. Alongside the growing interest in tissue engineering and the booming
of the electrospinning industry at the end of last century, non-thermal plasma technology
found its way into the biomedical field. Today non-thermal plasma treatment can be consid‐
ered as a well-established technique for the surface treatment of (bio)materials.
Before the start of the 21st century, the majority of contributions to scientific literature was
focussing on oxygen plasma treatments at low pressures and the corresponding response on
cell adhesion, growth and proliferation. Although today there is still a steady stream of
publications on these low pressure oxygen plasmas, there is a growing interest in atmospheric
pressure plasma treatments as they offer a number of practical advantages. In the next chapter
part, a detailed overview will be given on plasma technology in general and the different
treatments possible. After that, the chapter will continue on the use of plasma technology for
(bio)medical textiles, according to the application. At the end there will be a critical conclusion
and a look forward to the possible future of plasma technology for the biomedical textile
industry.
2. Non-thermal plasma technology
2.1. History and definitions
A plasma is a gaseous mixture of ions, radicals, electrons and neutrals. Plasma is often referred
to as the fourth state of matter, as its properties fundamentally differ from solids, liquids and
gasses and the change of state can be obtained by adding energy to a gas, similar to the
transition from solid to liquid to gas. In 1929, Langmuir was the first to actually define a plasma,
but already in the 19th century plasma was used on an industrial scale for the generation of
ozone (Siemens) [15].
Plasma itself can be divided up into two categories: 1) thermal or equilibrium and 2) non-
thermal or non-equilibrium plasma. Thermal or hot plasmas have temperatures of 4000 K or
higher and are considered to be in a thermal equilibrium, meaning that both heavy ions and
electrons have the same temperatures. Well known applications include plasma spraying,
wide arc spraying, and thermal plasma chemical vapour deposition (TPCVD), thermal plasma
synthesis of fine powders (nm), thermal plasma (toxic) waste destruction, thermal plasma
densification of powders, thermal plasma metallurgy, thermal plasma extractive metallurgy
etc. For non-thermal or cold plasma, only the electrons are accelerated via e.g. an applied
electrical field, causing a thermal inequilibrium between the electrons and the heavy particles.
This results in the formation of a plasma at lower temperatures. Due to this difference in
operating temperature between thermal and non-thermal plasmas, they are often referred to
as ‘hot’ and ‘cold’ plasmas respectively. Although referred to as cold plasma, temperatures of
up to 1000 K can be reached. For biomedical applications, non-thermal plasma treatments are
preferred with a degree of ionization of 1% or lower as this results in a discharge that can be
sustained at room temperature (290-330 K), thus avoiding thermal degradation of thermo-
sensitive materials. In the next paragraphs, the focus will be on the sources that are used to
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drive the discharge, as they are an excellent way to distinguish between the ways a plasma
can be generated, independent of the set-ups possible.
2.2. Plasma discharges
The different non-thermal or cold discharges discussed in the following parts have all proven
their usefulness as well as their limitations. Over time, applications have been found for each
different type of discharge in all branches of the industry: automotive, packaging, textiles,
aerospace, catalysis, waste treatment, (bio)medical etc. [9, 13, 16-18]. The number of plasma
reactor designs is nearly limitless and complete reviews have been written on that topic alone,
as design changes are made to optimize the plasma treatment for their specific application [19].
Most of the designs available today can be linked to one of the plasma sources discussed here.
2.2.1. Corona and silent discharge
A corona discharge reactor typically consists out of a cathode wire and an anode, which is
normally the material that needs treatment. The first developed systems were powered by a
DC source working in a pulsed mode and were operated at atmospheric pressure. When turned
on, the system generates a lighting crown build out of many streamers, hence the name corona
[9]. Pulses are used that are shorter than the time necessary to form an arc, thus avoiding the
transition to the spark regime. In the middle of 20th century, the first corona discharge systems
were patented for the incorporation into industrial textile production systems [20]. Later on,
the systems were adapted to work with high frequency sources (radio-frequency (RF),
microwave (MW) and AC) and today a number of commercial systems are available from
companies such as Tech Sales Company, Air Liquide, Acxys Technologies etc. These modern
high-tech set-ups are able to quickly and efficiently treat delicate structures such as electrospun
sheets. One of the main disadvantages of corona treatment is that the streamers always form
at the same sports, resulting in an inhomogeneous treatment of the exposed surfaces. To solve
this particular problem, there has been a shift to the usage of silent discharges [16].
A silent discharge, also known as a dielectric barrier discharge (DBD), is powered either via a
high frequency AC or an RF source. What makes the DBD stand out against other systems, is
its higher and broad pressure operating range (5-105 Pa) [21, 22]. In 1857, Siemens was the first
to use a DBD in a successful attempt to generate ozone and to this day it remains one of the
most important industrial applications of the DBD [15].
A DBD reactor typically consists of 2 electrodes, of which at least 1 is covered with a dielectric
material such as glass, ceramic or quartz. The voltage used to drive the discharge can start as
low as 0.5 kV and can be increased up to a few 100 kV. The generated plasma is a collection of
many small micro-discharges or streamers. The dielectric material is able to limit the discharge
current, giving cause to very short-lived micro-discharges (1-10 ns) that are distributed
homogeneously across the electrode. In some specific cases, the streamers can be avoided
altogether and a true glow regime can be obtained, which is considered the best case for
homogeneous treatments [9].
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DBD set-ups have one major advantage compared to most other systems: the possibility to
operate in a higher pressure range makes it possible to avoid extensive vacuum equipment.
This results in a lower operating cost and faster treatment cycles, thus allowing them to be
implemented in industrial surface modification processes. The low heat generation at elevated
pressures allows for a wider range of applications, including plasma chemistry, grafting,
polymerization, cleaning... These applications are not always as easily feasible in systems
powered with a different source.
It should be noted that occasionally in literature also the term corona discharge or corona
treatment is used in connection with DBDs, although most authors prefer to use this term only
for discharges between bare metal electrodes without dielectric.
2.2.2. DC discharge
Non-thermal plasmas generated via a DC discharge are in most cases formed in a closed set-
up between two electrodes at very low pressures (10-1 – 10 pa) [21, 22]. As the current is
increased, different types of discharges can be obtained. The Townsend discharge is a self-
sustaining discharge, typically characterized by a low current. A higher current results in a
drop of voltage and a glow discharge is generated. The glow discharge regime is the desired
regime for surface modifications, as it guarantees a homogeneous treatment al throughout the
reactor. Increasing the discharge current still further results in a fast increase of voltage until
an arc is formed, allowing for the charge to dissipate and the voltage drops almost completely.
One of the biggest advantages today of DC discharges, is that it is a well understood process,
allowing for a high control over the process and its different parameters.
The DC current can be driven through the system in a continuous manner, or it can be pulsed.
For biomedical applications in general, there are two advantages in doing the latter: first of,
higher discharge powers can be applied without the otherwise inevitable thermal damage
caused by the heating of the electrodes and secondly, if used for the coating applications, it
renders a more homogeneous coating. One of the main disadvantages of the DC driven systems
is the direct exposure of the electrodes to the plasma environment, making them prone to
corrosion if exposed to certain reactive monomers.
2.2.3. Radiofrequency and microwave discharges
Radiofrequency (RF) and microwave (MW) discharges are generated using high frequency
electromagnetic fields [21-23]. RF discharges have a relatively wide frequency operating range
between 1 – 100 MHz, but in most cases a fixed frequency of 13.56 MHz is applied. Concerning
the operating pressure, a wider range, compared to DC systems, (1-103 Pa) is possible, but with
the exception of a few, high-vacuum equipment is needed, which is expensive, drastically
increases treatment times and are hard to implement in continuous production processes. For
the treatment of biomedical materials, it is most likely the most applied discharge, as it is the
plasma treatment technique of choice for the popular oxygen plasma treatments and several
systems are commercially available.
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Microwave discharges are operated at a higher frequency range, usually fixed at 2.45 GHz.
The pressure range is more versatile compared to RF and DC discharges, with a range between
1 Pa and 105 Pa. Higher pressures lead in most cases to an increase of heat transfer from the
electrodes to the substrate, making it a less than ideal situation for the treatment of textiles and
nonwovens. This limitation results in the same treatment restrictions as the previously
discussed discharges.
2.2.4. Atmospheric pressure plasma jets
To finalize this chapter part on plasma technology, some special attention will be given to
atmospheric pressure plasma jets (APPJ’s). Operating a plasma in a confined space has certain
advantages when it comes to the control of the physics and chemistry taking place, but
sometimes there are cases where it would be more desirable if the plasma could be free from
any geometrical confinements. APPJ’s, also referred to as plasma plumes are an ideal solution
and are excellent tools for the treatment of geometrically larger and more complex surfaces
such as textile fibers [24].
APPJ’s can be powered with any of the sources discussed before, but all deal with the same
problem: how to avoid the transition from glow to arc. For DC sources this can either be
achieved via the use of hollow cathode discharges with sub mm dimension or the use of
resistive barrier discharges. For the DBD systems driven by high frequency AC sources, the
dielectric barrier itself is the solution, as it prevents the discharge current to increase to the
point of arcing. Under some special circumstances the DBD’s can generate an uniform diffuse
plasma that is filament free. For the RF powered APPJ, either a set-up similar to the DBD set-
up can be used, or the metal electrodes are left bare. For the latter, cooling of the electrodes is
required, as well as an excellent control of the flow rate in order to minimise the risk of arcing
[24]. Finally it is also possible to generate a plasma plume, using a microwaves to drive the
plasma, but it is limited to a strict set of geometrical parameters which has been described in
more detail by Park et al. [25].
It would be possible to give an extended description on the different set-ups available today,
but it would lead to far out of the scope of this chapter. Laroussi and Akan already wrote a
complete review on the different set-ups available. Also Shütze el al. wrote a compact review
on the physics behind several set-ups [22]. Since that time also a number of commercial systems
have become available on the market (crf Plasmatreat®, PlasmaSpot®, PlasmaStream®...). The
applicability of the APPJ for the treatment of biomedical textile will be covered in the following
chapter part 3: Plasma and textile: the biomedical applications.
2.3. Plasma-material interactions
In order to have an understanding of what is happening at the plasma-material interface, it is
critical to have a basic knowledge about the possible effects the different active species have
on a substrate exposed to them.
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2.3.1. Plasma cleaning and etching
During the production process and storage of (bio)materials, they can be exposed to a number
of solvents, greases, volatiles components etc. These contaminants will adsorb and accumulate
on the material surface over time, resulting in an altered, non-reproducible surface with a likely
reduced product performance. A typical example in the biomedical field, is the adsorption of
low molecular weight carbon species onto a pristine titanium sample, when exposed to
ambient air. When used as an implant material, this surface pollution results in a reduced cell
adhesion, proliferation and growth and in some cases even results in cell death [26, 27].
Any volatile surface contamination that is exposed to a non-thermal plasma, will be removed
in a few seconds [28]. Prolonged exposure to the plasma will not only result in the removal of
the adsorbed contamination but will cause etching of the top layers of the material surface
[29-32]. Depending on the density and hardness of the exposed material, more intense
discharges and/or extended exposure are required to obtain a notable effect. As (biomedical)
textiles are in most cases build out of relatively soft materials, the etching effect cannot be
overseen and will introduce a certain nano-roughness on the fiber surface. For in-vitro and in-
vivo applications this change in surface topography can have a benign effect, as it can amplify
the other effects plasma has on cell adhesion and proliferation [33-35].
2.3.2. Plasma activation
Plasma activation or plasma treatment is the exposure of a surface to the reactive particles
present in the plasma. This mixture of reactive particles will result in the incorporation of
radical sites on the surface, up to the depth of a few 10 nm. Depending on the gas used to
maintain the plasma, these sites will react (in)directly with other radicals present, recombining
into a broad variety of functional groups. These new functional groups have a high impact on
surface properties such as wettability and surface free energy, which in turn might have a
positive effect on material-material and material-cell interactions.
In most cases an increase in hydrophilicity is pursued to enhance the materials histological
performance. For some applications such as the surface of heart valves, the insides of needles
and tubes or artificial stents, any adhesion of cells and proteins is highly unwanted, as it can
lead to blockages resulting in premature failure of the biomedical device. Instead of using
typical gas feeds for plasma treatment (noble gasses, oxygen, dry air, nitrogen...), fluorinated
gasses such as CF4 are used which result in the formation of super hydrophobic surfaces withwater contact angles of 150° and higher. These fluorinated surfaces prevent cells and proteins
from effectively adhering on the surface and thus guaranteeing an optimal performance of the
implant material [11, 36, 37].
Plasma activation is definitely not the only technique available for the introduction of new
functional groups onto a surface, but as it is non-invasive and chemical-free, it guarantees the
preservation of even the most delicate structures.
2.3.3. Plasma grafting and polymerization
Non-thermal plasmas are not only applied for plasma treatments, but can also be used as an
initiation medium for radical polymerization, resulting in the deposition of a wide variety of
Advances in Bioengineering122
thin films. In order to optimize the bonding between the thin film and the biomaterial, the
deposition process is preceded by a plasma treatment, introducing radical sites that allow
covalent bonding of the polymer to the substrate surface. The polymerization process itself
can happen via two different reaction pathways: plasma polymer grafting simply uses the
radical sites introduced via plasma treatment to initiate the chain reaction. In other words,
during the polymerization process itself, no plasma is used and the monomer is not exposed
to the plasma. This results in the incorporation of the monomer as such, thus preserving its
functional groups.
For plasma polymerization this is not the case. The plasma is used as an initiation medium
and remains active during the entire polymerization reaction. This has as a consequence that
the monomer is exposed to the reactive plasma, forming initiation sites on both the substrate
surface as well as on the monomer. In contrast to chemical initiation, plasma is not as specific
as to where the radicals are formed, using any functional groups of the polymer precursor as
well to initiate the chain reaction. This results in a highly cross-linked, pinhole free and
completely amorphous thin film that significantly differs from its traditional counterpart and
adheres to almost any surface. Varying the discharge power gives a high control over the
amount of functionalities preserved in the film. From a biomedical viewpoint this is an
interesting application, as functional group density plays a critical role in the growth and
proliferation of cells and differs for the type of cells used.
3. Plasma and textile: The biomedical applications
3.1. Wound dressing
Optimal modern wound dressings should assure a moisture wound bed, help drainage,
remove debris of the wound surface, provide optimal thermal stability, might be removed
without trauma of the wound bed and wound edge, be antiallergenic and without immuno‐
genicity [38]. Over the years wound dressings have experienced a continuous development
stimulated by a better understanding of wound healing and bacterial growth mechanisms. In
more recent years research has shifted to targeted therapy by including different pharmaceut‐
ical compounds (e.g., antiseptics, analgetics, or growth factors) in to wound dressings. The
continuous presence, or controlled release of active substances, can tremendously stimulate
the healing process.
Non-thermal plasma technology has been part of this development process in many different
aspects of wound healing treatments. The review of the literature dealing with the use of
plasma technology for the enhancement of wound dressings will be divided according to the
purpose of the treatment: wound monitoring, enhancement antimicrobial properties, inter‐
mediate bonding, and adhesion.
3.1.1. Antimicrobial properties
Successful wound treatment cannot be achieved without keeping its two major aspects in
mind: maintaining a decent hydrophilicity and a high antimicrobial efficiency.
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In two different papers Persin et al. compared a few different treatment methods on viscose
fibers to address both of these aspects [39, 40]. In a first reaction pathway, a two-step process
consisting of an oxygen plasma treatment, followed by the immobilization of AgCl particles,
is followed. The alternative pathway consists of a single-step treatment of the cellulose fibers
with an ammonia plasma. The single-step treatment resulted in a 30-fold increase in water
uptake while the immobilization of the silver particles only had a marginal effect. For the
antimicrobial properties of the wound dressings, the reverse trend was found. The single-step
treatment only had an effect on Gram-positive bacteria, while the steady release of silver ions
resulted in a quasi-complete destruction of both Gram-positive and Gram-negative bacteria.
The authors therefore suggest to use a different treatment for different wound-healing
applications, depending on the risk of infection. In a third paper from the same authors, a closer
look is taken on the ageing of the plasma treated surfaces and the effect on the water up-take
[35]. The study showed that 4 days after the treatment, the water contact angle increased with
15° and the oxygen concentration decreased with less than 1%. These numbers suggest that
there is a limited shelf-lifetime of the modified wound dressings. Hacker et al. followed an
alternative strategy for the immobilization of Ag particles by plasma polymerizing PEG onto
electrospun PU mats, followed by soaking in AgNO3 and UV treatment, resulting in the
incorporation of metallic silver [41]. Water-uptake tests revealed a significant increase of
hydrosorption after 24 hours. The steady release of silver particles had a detrimental effect on
the viability of both Gram-positive and –negative bacteria while at the same time no cytotoxic
effects were noted on the adhesion and proliferation of fibroblasts. Further on in the chapter,
other strategies will be discussed to obtain antibacterial properties for other applications, but
it is already clear that the incorporation of silver particles with the help of plasma technology
is a successful pathway for the improvement of wound dressings.
Figure 1. SEM micrographs (3000×) of the (a) plasma modified nonwoven, (b) AAc coated nonwoven, (c) PP-g-collagen
nonwoven, and (d) PP-g-collagen-g-PNIPAAm nonwoven [126].
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3.1.2. Adhesion and intermediate bonding
Next to increasing the hydrophilicity of surfaces, plasma are also known to promote the
adhesion between layers. Gajanan et al. published two papers where plasma technology was
used to improve the adhesion between an electrospun material and a woven support structure
[42, 43]. In the first article chitosan was used as a raw material for the electrospinning process.
In the second article, the chitosan was mixed with silk fibroin. For both cases a 100% cotton
gauze was used as support material. Out of the different DBD plasma treatments, using He
+1% O, the combination of a pre-and post-treatment gave the best results. Flex durability tests
showed that there was a 4-fold increase in adhesion between the electrospun material and the
cotton gauze. On top of that SEM images showed that the plasma treatment resulted in a
reduction of the fibers’ delamination after repetitive flexing.
As explained earlier in section 2.3, plasma can be used to graft new side chains on polymer
substrates. The goal of grafting can either be to introduce new functional groups and use their
properties as such, or to introduce them as intermediates that can be used in consecutive
reactions. In biomedical surface engineering the latter is quite popular as the list of products
that can be used is limited, meaning that in most cases there is a sub-optimal affinity between
coating and substrate. Chen et al. used a PP-non-woven as a substrate on which acrylic acid
was grafted. The newly introduced carboxylic acid functionalities were used to either cova‐
lently bond collagen or chitosan, on which the thermo sensitive polymer PNiPAAm was
immobilized of which each step is depicted in figure 1. Above 32° C, the wound dressing
becomes hydrophobic and releases the stored moisture, which in turn resulted in an enhanced
wound healing [44, 45]. Lin et al. used an oxygen low pressure plasma to activate a PE non-
woven substrate, followed by the grafting of N-isopropyl acrylamide [46]. This intermediate
was then used for the covalent bonding of bovine gelatin. In-vivo tests revealed that the
covered wound healed completely (reached the maturation phase) and much faster compared
to the PE control.
The results discussed above show that plasma technology can be a valid, solvent-free alterna‐
tive for the permanent fixation of technically advanced layers onto standard substrates. Most
of the studies on adhesion and intermediate bonding are relatively new and more research is
needed to see if the obtained results can be extrapolated to other materials and applications.
3.1.3. Wound monitoring
In modern society the development of ‘smart’ materials is a hot topic (crf smartphones,
smartwatches, smart-TV’s etc.). In the wound care industry similar developments are taking
place and several groups are doing research on so-called ‘smart bandages’. The idea behind
smart bandages is that they autonomously could monitor the wound and signal in case of
infection or other irregularities. A few groups working on biosensors have successfully
incorporated plasma technology in their biosensor production process.
Phair et al. used a corona discharge in ambient air to activate carbon fiber threads in order to
improve their electro-analytical performance [47]. Via a redox probe set, the ion exchange rate
was determined as a function of plasma treatment time. The results showed that the incorpo‐
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ration of carboxyl groups resulted in better electron transfer kinetics. Exposing the prototype
bandage to whole blood proved that they were capable of detecting urates.
Zhou et al. developed a biosensor based on self-quenching fluorocarbons [48]. These fluoro‐
carbons were stored in lipid vessels which were immobilized on a pp-non-woven that was
plasma coated with maleic anhydride using a commercial RF discharge system. Upon contact
with both Gram positive and negative bacteria, the lipid vessels released the fluorocarbons,
allowing for a visual infection detection mechanism. In combination with the simultaneous
release of antibacterial products using the same release system, they believe it is possible to
make a quasi-autonomous or ‘smart’ bandage.
The collection of reviewed papers shows that non-thermal plasma technology can play an
important role in the development of smart bandages, allowing for low-cost personalized
wound care treatment.
3.2. Antimicrobial functionality
Within the section on wound dressings already a part on antibacterial properties of plasma
treated fibers has been included, but the applicability of these modified textiles goes much
further than wound treatment alone and is highly wanted for other (bio)medical applications
such as surgical gowns, sutures etc. as well as in the food industry and catering business [49].
The study on antimicrobial finishes of fibers and meshes has been quite extensive and between
25 and 30 papers will be reviewed here. A wide variety of substrates has been modified, ranging
from natural-based products such as cellulose and wool to PP, polyesters, polysulfons,
polyamides, carbon composites etc.
3.2.1. Ag immobilization
As for the modification itself, a distinction can be made between alterations involving the
immobilization of metal nanoparticles (Ag, Cu) and all other treatments. To this day, the
controlled release of silver particles is by far the most effective technique to inhibit the
attachment and growth of both Gram positive and negative bacteria [50-65]. Most of the
research groups use a non-thermal plasma to increase the wettability and nano-roughness of
the textile substrate in order to enhance the uptake of silver nanoparticles (either via AgNO3
or Agn) or a plasma polymer coating with controlled release properties. Antibacterial tests
involving micro-organisms such as E. Coli, S. Aureus and C. Albicans show in most cases a
bactericidal efficiency of more than 99.9%.
3.2.2. Plasma activation, grafting and intermediate bonding
Other research groups followed less known pathways with mixed success. Yao et al. did an
Ar low pressure plasma pretreatment of PVDF-HFP/PU fibrous membranes, followed by the
UV grafting of 4-vinylpyridine and a quaternization of the introduced pyridine group using
hexyl bromide [66]. Anti-bacterial essays showed a killing efficiency of 99.9999 % for both E-
Coli and S. Aureus strains (See figure 2). Despite the excellent performance of the fibers, the
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commercial applicability remains limited due to relatively expensive production process in a
competitive business environment.
Different research groups did a plasma pretreatment on cotton and polyproplyne (PP)
nonwovens respectively, followed by the immobilization of natural products [67-69]. Vaideki
et al compared the uptake of neem leaf extract before and after RF air plasma treatment and
found that both the increase in wettability as well as the surface etching resulted in a superior
adsorption of the extract [67]. Nitkyakalyani et al made a mix of herbal plant parts that were
dried and grinded after which they were dissolved so the PP could be soaked in it [68]. A wide
variety of both Gram positive and negative bacteria were tested and excellent antimicrobial
activity was noted. Although the use of natural products is a pro in some cases, it is difficult
to obtain a certain consistency in the production process and there is always a certain risk of
product pollution. Strnad et al. treated cellulose fibers with an RF O2 plasma to increase the
adsorption of chitosan [69]. The antimicrobial tests revealed a modest effect against S. Aureus
and no effect against E-Coli. Antifungal tests using several fungi strings resulted in modest
antifungal behavior.
Some groups simply applied a plasma treatment as such, using reactive gasses such as CF4
and hydrazine to obtain the desired antimicrobial effect. Uygun et al. did a pretreatment of
chitosan powder using a RF hydrazine plasma [70]. Chemical analysis shows a significant
increase in the number of primary amines present. Using the modified chitosan for the
electrospinning of nano-fibers results in a nonwoven that has a better moisture uptake and an
enhanced antibacterial effect for Gram-positive bacteria. Canal et al. and Virk et al. used an
Ar-CF4 post discharge plasma with mixed results. The treatment of wool, polyamide and
Sontara® resulted in a heightened bacterial resistance, while the treatment of cotton had no
effect at all [71, 72].
Just as described in the intermediate bonding paragraph of the wound treatment section,
plasma is used for the grafting of intermediate layers that are used for the immobilization of
antibacterial components. Degoutin et al. used a low pressure RF Ar plasma to graft acrylic
acid onto a PP nonwoven [73]. The carboxylic acid functionalities were used for the immobi‐
lization of gentamicin, which is known to be 99% bactericidal as was confirmed by the testing
with E. Coli. Gawish et al. used a He plasma for the grafting of glycylmethacrylate, which was
used for the covalent bonding of cyclodextrines [74]. These macromolecules are known for the
controlled release of active components, in this case biocides with antimicrobial and insect
repellent properties. These experiments confirm that plasma grafting is a versatile technique
that forms the basis for subsequent reactions.
In general it can be concluded that the incorporation of silver micro-and nano-particles is still
the golden standard for the production of antibacterial textiles. Non-thermal plasma technol‐
ogy can be a useful tool for the immobilization of the metal particles and plasma deposited
coatings are ideal for the controlled release. Plasma treatments as such can generate highly
antimicrobial surfaces, as was proven, amongst others, by Yao et al. [66], but only after the
right selection of precursors and discharge gasses.
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Figure 2. SEM images of (a) and (d) filter paper (control), (b) and (e) pristine, and (c) and (f) modified PU fibrous mem‐
branes after immersed in PBS suspension of (a)–(c) S. Aureus, or (d)–(f) E. Coli at 107 cells/mL for 4 h. PU fibrous mem‐
branes were electrospun from 10% (w/v) solutions in THF and DMF (1:1, v/v) [127].
3.3. Cell culture and soft tissue engineering
Technical textiles for tissue engineering applications are one of the youngest branches in the
textile industry, but in a just a few decades they have become a major player on the biomedical
market and the number of publications dealing on the theme of tissue engineering applications
has exponentially grown. The idea behind tissue engineering is that (stem) cells are extracted
Advances in Bioengineering128
from a patient with a malfunctioning organ. The retrieved healthy cells are seeded on a culture
plate and grown to a full culture [3, 4, 75]. Once enough cells can be harvested, they are seeded
onto a 3D nanofibrous scaffold. After a certain incubation period, allowing the cells to grow
and differentiate into the scaffold, the nonwoven is implanted into the patient in order to
restore the organ functionality or replace the organ as such. By treating patients with their own
cells, immuno-response can be reduced to an absolute minimum and it is considered to be a
constructive solution for the transplant waiting list issue.
In this specific chapter part, both the enhancement of cell culture applications as well as soft
tissue engineering will be discussed together, as they are closely related and in some cases
even overlap. This chapter part will therefore be subdivided into a first section dealing with
plasma treatment as such and its effect on cell growth, adhesion, proliferation and differen‐
tiation and a second section handling plasma grafting and polymerization, talking in more
detail about adhesion and homogeneity of the deposited coatings as well as the histological
properties.
3.3.1. Plasma treatment
The most widely used polymer collection for the production of nonwoven scaffolds for tissue
engineering is the biodegradable polymer family. Polylactic acid(PLLA), polylactic-glycolic
acid (PLGA), Polycaprolacton (PCL)... are well established biomaterials due to the fact that
after implantation they get broken down by the body in harmless end products (ideally CO2
and H2O) that can be secreted by the body, making a second surgery no longer necessary [13,
76]. The mechanical and structural properties of these materials are sufficient for their field of
applications. The biocompatibility and bioactivity on the other hand are mediocre at best and
often inhibit the migration and differentiation of cells into the textile scaffold structure [77,
78]. The surface treatment of these scaffolds is rather complicated, as the pore size limits the
infiltration efficiency of (wet)-chemical treatments and often degrade the structural stability
of the delicate nano-fibers. Gas-based treatments such as non-thermal plasmas are promising
to penetrate more easily into the electrospun scaffold structure and are at the same time known
for the fact that they only alter the surface without affecting the bulk, guaranteeing the
mechanical and structural integrity of the modified biomaterial [14, 79].
The contact angle of PCL electrospun scaffolds lies between 120° and 140°, indicating a
hydrophobic surface, which is not well liked by most cells. After treatment with either air, Ar,
NH3 or O2 plasmas, all research groups were able to reduce the contact angle to less than 5°
[80-85]. The XPS results reveal an increase in the oxygen content with the incorporation of a
mixture of C-O, C=O and O-C=O functional groups. Prabhakaran et al. seeded neurolemmo‐
cytes (or Schwann) cells onto the nanofibrous scaffolds and found an increase in proliferation
rate at all times, with a maximum of 17% compared to the untreated material after 10 days,
compared to the untreated scaffolds [80]. They claim that the treatment is as effective as a
collagen coating, making it a cost-effective alternative for nerve cell regeneration applications.
Yan et al. found that after plasma treatment with NH3+O2 had no influence on the mechanical
properties of the non-woven. After seeding with MC3T3 osteoblasts a 2-3 times increase in cell
adhesion was found in the first 24 hours and after 7 days the proliferation was increased by a
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factor of 6, making the plasma treatment an excellent tool for the introduction of osteo-
inductive properties [81, 84]. Martins et al. came to the same conclusions after treating their
PCL nano-textile scaffolds both with Ar and O2 plasma [82]. Seeding 3 different cell lines (L929,
ATDC5 and Saos-2) covering a wide variety of cell-types, resulted in a significant increase in
both adhesion and proliferation for all cells. Min et al. tested the O2 plasma treated PCL nano-
textile with primary astrocytes and noted an increase in adherence and viability in the first 24
hours [83]. Jeon et al. used a nano-sized template to enhance the nano-roughness introduced
by the plasma [85]. After seeding MG63 osteoblasts a dramatic increase in cell adhesion and
proliferation were noted as well as an elongated morphology compared to both untreated PCL
and PCL treated without the nano-sized template, showing that both the surface chemistry
and topography have a significant influence on the histological performance of the PCL
electrospun scaffolds. Finally Blackstone et al. used a CF4 plasma to further increase the contact
angle of the non-woven in order to obtain a superhydrophobic scaffold [86]. After seeding a
mixture of fibroblasts, keranocytes and MCF-7 cancer cells, they were able to sort out the cancer
cells by applying a fixed amount of stress to the textile. The recovered cancer cells did not
change in morphology, allowing for post-sorting analysis, making the development of a low
cost cancer detection device possible.
Figure 3. Photographs of water droplets taken immediately after contacting (a) non-treated, (b,c) oxygen plasma-treat‐
ed and (d,e) ammonia plasma-treated PLGA nanofibers. Treatment time was varied from (b,d) 30 to (c,e) 180 s [128].
PLLA and PLGA both exhibit the same hydrophobic properties as PCL non-woven, giving
water contact angles situated between 130° and 150°. After a plasma treatment with the typical
discharge gasses (O2, Ar, NH3...) a decrease in contact angle was found to a minimum, ranging
between 20° and 45° as depicted in figure 3 [87-89]. XPS reveals that PLLA is less robust
compared to PCL as the initial increase in oxygen content is reversed when the substrate is
over-treated, resulting in etching/degradation of the polymer structure [88]. Both Park et al.
and Dolci et al. seeded fibroblasts (NIH 3T3 and MEF) after NH3 and air treatments respectively
and similar results for the increase in viability and elongated morphology were found [88,
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90]. Liu et al. did a study on the adhesion behavior before and after O2 plasma treatment of
pMSC cells in the first hour after seeding [89]. Results revealed that both the adhesion and cell
morphology were greatly improved as can be seen from figure 4. These results show that
plasma treatment is indeed a valid option for the culturing of stem cells.
As PLLA, PLGA and PCL all show similar histological effects after exposure to a wide variety
of plasmas, it is no surprise that blends of PLLA and PCL exhibit similar behavior. Chanda‐
sekaran et al. exposed such a co-polymerized fiber mesh to an air plasma treatment and studied
the effects on fibroblast growth and proliferation [91]. In both cases a significant increase was
noted and stimulation of extra cellular matrix formation was found, opening up the possibility
for skin tissue regeneration applications.
Figure 4. SEM images of pMSCs on Plasma treated PLLA nanofibers (NFS) and pristine PLLA NFS. (A–D) pMSCs on
PLLA NFS after cultured for 10 min, 20 min, 30 min,60 min, respectively; (E–H) pMSCs on P-PLLA NFS after cultured
for 10 min, 20 min, 30 min,60 min, respectively; (a–h) higher magnification for (A–H) [129].
The biodegradability of the textile scaffold material is not required in every case and sometimes
has to be avoided all together (tissue culture ‘plates’, vascular grafts...) as the loss of the
mechanical framework would result in the permanent failure of the implant. A polystyrene
electrospun scaffold was treated by Baker et al. with a low pressure Ar plasma, followed by
the seeding of smooth muscle cells [92]. The in-vitro tests revealed a significant increase in cells
and an alignment with the electrospun material. The excellent results show that the polystyr‐
ene electrospun scaffold could be a valid alternative for 2D tissue culture plates. Zandén et al.
treated a PU fiber mesh with an oxygen plasma in an attempt to improve the interaction with
red blood cells [93]. SEM images showed that prolonged exposure to the plasma resulted in a
reduction of the fiber diameter and finally the degradation of the structure. As was the case
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with PLLA and PCL, a significant increase in hydrophilicity was noted due to the incorporation
of polar functional groups. The in-vitro tests revealed that there was no significant difference
between the adhesion of red blood cells before and after treatment. This shows that not all
plasma treatments have a positive effect on biocompatibility and that the treatment gas and
operation parameters should be carefully selected.
The final paragraph of this chapter part on plasma treatment for tissue engineering will go
over the possibilities to use non-thermal plasmas to stimulate the formation of apatite on
flexible scaffold structures. Yang et al. immersed an Ar plasma treated PCL fiber structure in
an SBF 10 solution for a period of 7 days [94]. In the first 24 hours, already a CaP coating had
grown on the fibers, consisting of nano-apatite and dicalcium phosphate dehydrate. After 7
days a structure closely resembling bioapatite was found. Luo et al. performed the same
analysis on air plasma treated PEEK (reinforced with carbon fiber) and whereas the untreated
PEEK resulted in no apatite formation, a fully grown apatite layer could be found on the treated
nonwoven scaffold [95]. Other research groups made a solution of PCL mixed with hydrox‐
yapatite/CaCO3 which was electrospun, resulting in a composite nano-textile which was
followed by an oxygen/air plasma treatment [96, 97]. After seeding hFOB osteoblasts, a
significant proliferation rate was noted, as well at the first signs of mineralization similar to
human bone as depicted in figure 5. These papers show that plasma activation of polymeric
nonwoven scaffolds is an excellent tool for the promotion of apatite growth.
Figure 5. Mineralization of hFOB on PCL/HA-P nanofibrous scaffolds at different magnifications: (a) mineral deposi‐
tion 5000× (6 days), (b) mineral deposition 10000× (6 days), (c) mineral deposition 15000× (6 days), (d) apatite-like mor‐
phology of natural bone 15000× (10 days) [130].
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In general it can be concluded that non-thermal plasma treatments, both at lower and elevated
pressures, are excellent tools for the stimulation of the histological properties of a wide variety
of cells seeded onto flexible scaffolds for tissue culture and tissue engineering applications.
3.4. Plasma grafting, polymerization and immobilization
The tissue engineering nanofibrous scaffold materials subjected to plasma grafting and plasma
polymerization are, in the majority of the papers reviewed, more or less the same ones used
for plasma activation, PCL being the most popular one. A minority of papers investigated less
obvious material choices that are inherently not (sufficiently) biocompatible, but once coated
exhibit sufficient bioactive properties, as will be discussed in the last paragraph of this chapter
part.
Guex et al. coated a PCL mesh using a combination of ethylene and CO2 in an Ar discharge in
order to restore the functionality of damaged myocardium [98]. After seeding extracted
mesenchymal stem cells onto the modified electrospun scaffold, it was implanted in a rodent
model. Post-mortem analysis revealed a stabilized cardiac functionality as well as an attenu‐
ated dilation. Zander et al. covalently bonded lamilin proteins onto an air plasma treated PCL
scaffold [99]. PC12 neuron-like cells were seeded onto the modified substrate and analysis
showed a positive correlation between the neuron outgrowth and the concentration of the
immobilized proteins. Xie et al followed a similar strategy, immobilizing dopamine [100]. The
dopamine coating itself was then used to immobilize fibronectin, which significantly stimu‐
lated the attachment, spreading and cytoskeletal development of NIH 3T3 cells. Furthermore
it was proven that the coatings could be used for the controlled release of active substances.
Ma et al. used a combination of air plasma and wet carboiimide chemistry to graft gelatin onto
both random and aligned PCL fiber meshes [101]. The spreading and proliferation of endo‐
thelial cells was greatly enhanced and the cells aligned themselves along the fibers, which was
not the case for the untreated material. Finally Hegeman et al. performed a degradation study
of PCL nanofibrous scaffolds coated with amine containing polymers and showed that the
incorporation of oligomers in the deposited films can leach out, causing cell death [102].
Storage of the coated nano-textiles in liquid media removed the low molecular weight residue,
solving the problem. Overall, the literature shows that PCL nonwoven scaffolds, either
activated or coated, can be used for a wide variety of tissue engineering applications, exhibiting
excellent bioactive properties. It is essential though to use the right set of parameters and avoid
the inclusion of unreacted products as this can have a detrimental effect on the histological
performance of the 3D electrospun scaffold.
Several research teams used non-thermal plasmas to immobilize bioactive macromolecules
(collagen, cRGD peptides and heparin respectively) onto a PLLA nano-textile scaffold, after
which they were seeded with either BOECs, hMSC or endothelial cells [78, 103-106]. In all cases
a positive influence was found on the scaffold’s histological properties. Park et al. also obtained
an increase in adhesion and proliferation after seeding NIH 3T3 fibroblasts onto PLLA nano-
textile scaffolds that were grafted with an acrylic acid coating using a low pressure O2 plasma
[107]. He et al and Chan et al. performed a similar procedure compared to Feng et al. to
immobilize collagen onto PLLA-PCL electrospun scaffolds [108, 109]. The first group success‐
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fully seeded hCAEC’s, showing the possibilities for vascular grafts (see figure 6), while the
Chan et al. studied the enhancement of the adsorption properties of MSC cells in the first hour
after seeding, proving that coated nonwoven scaffolds are more efficient than plasma treated
samples, which in turn are more effective then untreated samples.
A rather large number of publications can be found on a variety of other biomaterials that are
not always biodegradable such as PDMS, PU, PET, silk fibroin, cellulose, PHBV... Most of these
textile scaffolds get coated with well-known bioactive macromolecules such as collagen,
galactose, lamilin, peptides, or polymer films containing functional groups that are well-liked
by cells, such as primary amines or carboxylic acids [92, 110-118]. A whole spectrum of cells
is seeded on the coated textile scaffolds, ranging from osteoblasts and fibroblasts to endothelial
cells, nerve cells and even stem cells. Discussing all of them again would lead to far, especially
as the effects are similar to the histological performance of the coated PCL and PLLA textiles.
Therefore the results have been summarized in table 1.
Figure 6. Fluorescent micrographs of HUVECs cultured on PU (A and B), plasma treated PU (P-PU) (C and D), P-PU/
PLGA (E and F), and plasma treated (P-PU/PLGA) films for 3 s (G and H). Cells were stained with Texas-Red Malei‐
mide C2 for cell membrane and nuclei were stained with Hoechst33258. Images are 40× (A, C, E, and G) and 400× (B, D,
F, and H) magnified [131].
Scaffold
material
Plasma
treatment
Deposited
coating Cell line
Histological
Effects Authors Reference
Silk fibroin RF Ar lowpressure Heparin
L929
EVC
Better
proliferation Wang et al. [110]
PDMS RF Ar lowpressure pNIPAm aoSMC
Smooth muscle
cell formation
Rayatpishesh et
al. [111]
PU RF O2 lowpressure Galactose HepG2/C3A
Improved
albumin secretion Chien et al. [112]
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Scaffold
material
Plasma
treatment
Deposited
coating Cell line
Histological
Effects Authors Reference
PCL + starch RF O2 lowpressure
Vinyl sulphonic
& phosphonic
acid
Fibronectin
Vitronectin
Saos-2
Enhanced protein
adsorption &
better cell growth
and proliferation
López-Pérez et
al. [113]
PET RF C2H4 lowpressure NH3 HUVEC
Better growth and
proliferation Savoji et al. [114]
PES MW O2 lowpressure Collagen USSC
Excellent
infiltration Shabani et al. [115]
PS Ar Lamilin Smooth musclecells
Enhanced
differentiated
phenotype
Baker et al. [92]
PSU RF air cleaner Methacrylic acid+ F3GA BSA
Fast purification
small scale
proteins
Ma et al. [116]
Cellulose APPJ Ar f-Cyclodextrines Fatty acids
Excellent
inclusion & no
cytotoxicity
Nada et al. [117]
PC-PU RF O2 lowpressure PDMS L929 Cytocompatibility Arjun et al. [118]
Table 1. Overview of papers on the histological performance of plasma coated 3D electrospun scaffolds (no PCL and
PLLA)
3.5. Sutures
Of all the textiles for biomedical applications, sutures are probably the most low-tech. The
amount of research conducted to improve the performance of surgical sutures is therefore not
as extensive. Traditionally sutures were either non-biodegradable, requiring removal after‐
wards or biodegradable, but lacking the necessary mechanical strength and flexibility [49].
Eventually glycolide and lactide polymers such as PLLA and PLGA found their way into the
suture market, introducing the required mechanical properties combined with biodegrada‐
bility. Yet, as has been discussed earlier in the chapter, these biodegradable polymers do not
always exhibit the wanted bioactive surfaces. A small number of research groups have
investigated if non-thermal plasma technology can help to further improve the performance
of medical sutures, of which a brief overview will be given.
Loh et al. performed a study, using both activation and deposition, analyzing the hydrolytic
degradation rate of commercially available synthetic absorbable sutures [119, 120]. Dexon
(PGA), Vicryl (PGLA), PDS11 (PpDO) and Maxon were either coated with parylene or treated
by a number of different plasma gasses. Using the right set of plasma treatment parameters
significantly increased the degradation rate of Vicryl and PDS11, while for Dexon and Maxon
Plasma Modified Textiles for Biomedical Applications
http://dx.doi.org/10.5772/59770
135
only marginal differences were found. The plasma coating process, using parylene, resulted
in an increase in tensile strength, most likely due to the hydrophobic character of the coating.
Saxena et al. published 3 papers on plasma grafting of PP sutures [121-123]. In all the articles
an RF O2 plasma was used to activate the monofilament, followed by the immersion in an
acrylic acid solution. The introduced carboxylic acid groups were then used to successfully
immobilize chitosan. While the first 2 articles elaborates on the preservation of the mechanical
properties and the surface chemical characterization, the second article focusses more on the
antimicrobial, in-vitro and in-vivo properties. The viability of both E. Coli and S. Aureus were
reduced with more than 90%. The in-vitro studies revealed excellent adhesion and prolifera‐
tion of MC3T3 cells and the in-vivo use in a rodent resulted in a better quality of tissue
integration and a minimal inflammatory response. The grafting of acrylic acid onto a mono‐
filament for improved antimicrobial functionality was inspired by Gupta at al. who grafted
acrylic acid onto PET monofilaments, obtaining similar antimicrobial results [124, 125].
 
Figure 7. Left: Zone of inhibition against E. Coli (a) control PP suture and (b) drug-loaded PP suture (degree of graft‐
ing, 5%). Middle: Zone of inhibition against K. Pneumonia (a) control PP suture and (b) drug-loaded PP suture (degree
of grafting, 5%). Right: Zone of inhibition against S. Aureus (a) control PP suture and (b) drug-loaded PP suture (de‐
gree of grafting, 5%) [132].
Albeit being a rather low-tech application, plasma technology is still able to improve the
performance of medical sutures. If the results found for tissue engineering applications would
be applied for monofilament applications, it is beyond doubt that the biomedical properties
could be further enhanced.
4. Conclusion
In this chapter a broad range of applications has been reviewed where non-thermal plasma
technology could play a beneficial role in the biomedical performance of technical textiles.
Albeit being more limited in the number of functional groups that can be incorporated and the
limited stability over time, plasma activation still leads to improvements in cell viability,
adhesion, proliferation and differentiation as well as better adsorption and chemical bonding
of bioactive and bactericidal macromolecules. Plasma grafting and polymerization is equally
able to do all of the above, while having access to a wider variety of functional groups and
Advances in Bioengineering136
results in more stable surfaces. The incorporation of low molecular weight species into the
coatings has to be avoided at all costs as they can have a detrimental effect on the cells viability.
Up to now, the low pressure systems are by far the most used treatment systems, as the physics
behind the process are well understood and multiple systems are commercially available. In
the last decade there has been a growing interest in atmospheric pressure systems as they are
more low-cost and can be more easily incorporated in textile production systems and it is our
personal believe that atmospheric pressure systems such as the plasma jets will become the
most prominently used set-ups. All in all it can be concluded that non-thermal plasma
technology has earned its place in the (bio)medical textile market and will continue to do so
in the future.
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